DK1200129T3 - Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser - Google Patents

Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser

Info

Publication number
DK1200129T3
DK1200129T3 DK00945340T DK00945340T DK1200129T3 DK 1200129 T3 DK1200129 T3 DK 1200129T3 DK 00945340 T DK00945340 T DK 00945340T DK 00945340 T DK00945340 T DK 00945340T DK 1200129 T3 DK1200129 T3 DK 1200129T3
Authority
DK
Denmark
Prior art keywords
ion exchange
oral liquid
exchange resins
taste masking
quinolone
Prior art date
Application number
DK00945340T
Other languages
Danish (da)
English (en)
Inventor
Rong Gao
Zezhi Jesse Shao
Allan Chor-Lun Fan
Leonore Cat Witchey-Lakshmanan
Daniel Charles Stewart
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Application granted granted Critical
Publication of DK1200129T3 publication Critical patent/DK1200129T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00945340T 1999-07-14 2000-07-12 Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser DK1200129T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35354999A 1999-07-14 1999-07-14
PCT/US2000/018948 WO2001005431A1 (en) 1999-07-14 2000-07-12 Taste masking of oral quinolone liquid preparations using ion exchange resins

Publications (1)

Publication Number Publication Date
DK1200129T3 true DK1200129T3 (da) 2009-01-12

Family

ID=23389610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00945340T DK1200129T3 (da) 1999-07-14 2000-07-12 Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser

Country Status (24)

Country Link
EP (1) EP1200129B1 (de)
JP (2) JP2003504416A (de)
AR (1) AR024715A1 (de)
AT (1) ATE411047T1 (de)
AU (1) AU777993B2 (de)
BG (1) BG65656B1 (de)
BR (1) BR0012439A (de)
CA (1) CA2378894C (de)
CY (1) CY1108801T1 (de)
CZ (1) CZ302919B6 (de)
DE (1) DE60040540D1 (de)
DK (1) DK1200129T3 (de)
ES (1) ES2313897T3 (de)
HU (1) HUP0202229A3 (de)
IL (2) IL147242A0 (de)
MX (1) MXPA02000501A (de)
NO (1) NO20020134D0 (de)
NZ (1) NZ516536A (de)
PL (1) PL202027B1 (de)
PT (1) PT1200129E (de)
SI (1) SI1200129T1 (de)
SK (1) SK287415B6 (de)
WO (1) WO2001005431A1 (de)
ZA (1) ZA200200026B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
JP5009707B2 (ja) * 2007-07-10 2012-08-22 東和薬品株式会社 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤
EA023294B1 (ru) * 2010-05-19 2016-05-31 Астеллас Фарма Инк. Фармацевтическая композиция, содержащая солифенацин

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
WO1993005816A1 (en) * 1991-09-17 1993-04-01 Alcon Laboratories, Inc. Compositions containing quinolone antibiotics and sulfonate of polystyrol
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
DE69419281T2 (de) * 1993-04-28 2000-03-23 Takeda Chemical Industries Ltd Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物

Also Published As

Publication number Publication date
ES2313897T3 (es) 2009-03-16
CA2378894C (en) 2005-11-22
EP1200129A1 (de) 2002-05-02
SK287415B6 (sk) 2010-09-07
ATE411047T1 (de) 2008-10-15
PT1200129E (pt) 2008-12-17
EP1200129B1 (de) 2008-10-15
HUP0202229A3 (en) 2008-10-28
CZ302919B6 (cs) 2012-01-18
IL147242A0 (en) 2002-08-14
AR024715A1 (es) 2002-10-23
BG65656B1 (bg) 2009-05-29
JP2011246497A (ja) 2011-12-08
IL147242A (en) 2008-12-29
AU777993B2 (en) 2004-11-11
CA2378894A1 (en) 2001-01-25
NO20020134L (no) 2002-01-11
BR0012439A (pt) 2002-04-02
AU5930200A (en) 2001-02-05
CY1108801T1 (el) 2012-05-23
DE60040540D1 (de) 2008-11-27
ZA200200026B (en) 2003-04-02
NO20020134D0 (no) 2002-01-11
PL202027B1 (pl) 2009-05-29
JP2003504416A (ja) 2003-02-04
HUP0202229A2 (hu) 2002-11-28
NZ516536A (en) 2003-09-26
SK532002A3 (en) 2002-05-09
SI1200129T1 (sl) 2009-06-30
MXPA02000501A (es) 2002-07-02
PL352183A1 (en) 2003-08-11
BG106329A (en) 2002-08-30
WO2001005431A1 (en) 2001-01-25
CZ200271A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
PT1226188E (pt) Processo de preparacao de aductos de mannich contendo poliisobutileno fenol
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
ATE537831T1 (de) Orale aripiprazol-lösung
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
ATE485823T1 (de) Kombinationspräparate enthaltend (e)-7-ä4-(4- fluorophenyl)-6-isopropyl-2-
DK1392307T3 (da) Tartratsalte af 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen
NO20032187L (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1210085T3 (da) Farmaceutiske oplösninger af levosimendan
NO20031144L (no) Klargjöringssystem for konsentriske rör
DK1165138T3 (da) Programmeret, kontrolleret ovarial stimulationsprotokol ved anvendelse af orale svangerskabsforebyggende midler
DK1263717T3 (da) Fremgangsmåde til fremstilling af methionin
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
NO20024956L (no) Fremgangsmåte for fremstilling av ionebyttemembraner
DK1200129T3 (da) Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1155050T3 (da) Fremstilling af polyolefin
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20040205L (no) Farmasøytiske preparater inneholdende ionebytterharpikser belagt med virksomt stoff
DE60132526D1 (de) Farbregistrierungssystem
DK1043025T3 (da) Behandling af nyrecellekarcinom
DK1088010T3 (da) Fremstilling af polyolefiner